.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Army
McKinsey
Mallinckrodt
Harvard Business School
Citi
Federal Trade Commission
Cipla
Moodys
Teva

Generated: June 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lorcaserin hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc
BELVIQ XR
lorcaserin hydrochloride
TABLET, EXTENDED RELEASE;ORAL208524NDAEisai Inc.62856-535-301 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62856-535-30)
Eisai Inc
BELVIQ
lorcaserin hydrochloride
TABLET;ORAL022529NDAEisai Inc.62856-529-6060 TABLET in 1 BOTTLE (62856-529-60)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Argus Health
Healthtrust
Chinese Patent Office
Harvard Business School
McKinsey
Cerilliant
Dow
Fish and Richardson
Covington

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot